Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A novel treatment approach to a type II endoleak at endograft implantation using components of an endosensor monitoring device.
Adiantum
Galanthus
Gut bacterial deamination of residual levodopa medication for Parkinson's disease.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Gut bacterial deamination of residual levodopa medication for Parkinson's disease.
Gut bacterial deamination of residual levodopa medication for Parkinson's disease. BMC Biol. 2020 10 20; 18(1):137.
View in:
PubMed
subject areas
Animals
Antiparkinson Agents
Clostridium
Deamination
Gastrointestinal Microbiome
Gastrointestinal Motility
Levodopa
Male
Mice
Mice, Inbred C57BL
Parkinson Disease
Transaminases
authors with profiles
Ali Keshavarzian